4//SEC Filing
Cidara Therapeutics, Inc. 4
Accession 0001209191-17-024889
$CDTXCIK 0001610618operating
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:43 PM ET
Size
5.6 KB
Accession
0001209191-17-024889
Insider Transaction Report
Form 4
Onaitis Matthew
Gnrl Counsel, CFO & Secretary
Transactions
- Award
Employee Stock Option (right to buy)
2017-03-31+55,000→ 55,000 totalExercise: $7.80Exp: 2027-03-30→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 31, 2017.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001610618
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:43 PM ET
- Size
- 5.6 KB